Kuano Company

Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.


Connections from

Total Funding: 1000000.0
Headquarters: London, England, United Kingdom
Funding Status: Seed
Employee Number: 13
Last Funding Type: Seed
Technology: Medical BioTech
Last Funding Date: 2021-07-08
Investors Number: 4.0
Founded Date: 2020-01-01
Industry: Medical BioTech